» Articles » PMID: 38612650

Chagas Disease: A Silent Threat for Dogs and Humans

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 13
PMID 38612650
Authors
Affiliations
Soon will be listed here.
Abstract

Chagas disease (CD) is a vector-borne Neglected Zoonotic Disease (NZD) caused by a flagellate protozoan, , that affects various mammalian species across America, including humans and domestic animals. However, due to an increase in population movements and new routes of transmission, infection is presently considered a worldwide health concern, no longer restricted to endemic countries. Dogs play a major role in the domestic cycle by acting very efficiently as reservoirs and allowing the perpetuation of parasite transmission in endemic areas. Despite the significant progress made in recent years, still there is no vaccine against human and animal disease, there are few drugs available for the treatment of human CD, and there is no standard protocol for the treatment of canine CD. In this review, we highlight human and canine Chagas Disease in its different dimensions and interconnections. Dogs, which are considered to be the most important peridomestic reservoir and sentinel for the transmission of infection in a community, develop CD that is clinically similar to human CD. Therefore, an integrative approach, based on the One Health concept, bringing together the advances in genomics, immunology, and epidemiology can lead to the effective development of vaccines, new treatments, and innovative control strategies to tackle CD.

Citing Articles

Fighting Strategies Against Chagas' Disease: A Review.

Hernandez-Flores A, Elias-Diaz D, Cubillo-Cervantes B, Ibarra-Cerdena C, Moran D, Arnal A Pathogens. 2025; 14(2).

PMID: 40005558 PMC: 11858460. DOI: 10.3390/pathogens14020183.


The Impact of Environmental and Housing Factors on the Distribution of Triatominae (Hemiptera, Reduviidae) in an Endemic Area of Chagas Disease in Puebla, Mexico.

Ortega-Caballero M, Gonzalez-Vazquez M, Hernandez-Espinosa M, Carabarin-Lima A, Mendez-Albores A Diseases. 2024; 12(10).

PMID: 39452481 PMC: 11506842. DOI: 10.3390/diseases12100238.


Evaluation of chimeric recombinant antigens for the serodiagnosis of Trypanosoma cruzi in dogs: a promising tool for Chagas disease surveillance.

Fontes N, Habib F, Leony L, Freitas N, Silva A, Dantas-Torres F Parasit Vectors. 2024; 17(1):305.

PMID: 39010122 PMC: 11251128. DOI: 10.1186/s13071-024-06376-5.


Editorial: Neglected tropical diseases: tackling the challenges of a global world.

Rodrigues A, Santos-Gomes G Front Toxicol. 2024; 6:1417438.

PMID: 38745693 PMC: 11091868. DOI: 10.3389/ftox.2024.1417438.

References
1.
Calvet C, Silva T, Thomas D, Suzuki B, Hirata K, Siqueira-Neto J . Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole. PLoS Negl Trop Dis. 2020; 14(9):e0008726. PMC: 7561097. DOI: 10.1371/journal.pntd.0008726. View

2.
Basso B, Castro I, Introini V, Gil P, Truyens C, Moretti E . Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi. Vaccine. 2007; 25(19):3855-8. PMC: 7127752. DOI: 10.1016/j.vaccine.2007.01.114. View

3.
Matsuda N, Miller S, Barbosa Evora P . The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo). 2009; 64(12):1219-24. PMC: 2797592. DOI: 10.1590/S1807-59322009001200013. View

4.
Requena-Mendez A, Albajar-Vinas P, Angheben A, Chiodini P, Gascon J, Munoz J . Health policies to control Chagas disease transmission in European countries. PLoS Negl Trop Dis. 2014; 8(10):e3245. PMC: 4214631. DOI: 10.1371/journal.pntd.0003245. View

5.
Hasslocher-Moreno A, Xavier S, Magalhaes Saraiva R, Sangenis L, de Holanda M, Horta Veloso H . Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort. Trop Med Infect Dis. 2020; 5(2). PMC: 7345528. DOI: 10.3390/tropicalmed5020076. View